Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
5
×
biotech
boston blog main
boston top stories
cancer
5
×
deals
5
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biontech
cancer drugs
clinical trials
eli lilly
ipo
merck
moderna
pfizer
startups
takeda pharmaceutical
What
bio
roundup
buy
cancer
drug
moves
acquisitions
alliance
appetite
becker
biggest
billions
black
bread
bristol
build
butter
buyout
calls
cash
ceo
changing
color
company’s
crispr
daniel
days
debut
despite
diabetes
diamond’s
dollars
drugs
dyne’s
eaton
eli
family
gene
giant
gilead
Language
unset
Current search:
deals
×
cancer
×
amgen
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More